164 related articles for article (PubMed ID: 11599107)
21. Clinical significance of reporting benign-appearing endometrial cells in Pap tests in women aged 40 years and over.
Jones E; Frain BM; Crabtree W
Acta Cytol; 2009; 53(1):18-23. PubMed ID: 19248550
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of a cytologic diagnosis of atypical glandular cells, favor endometrial origin, in Pap smears.
Saad RS; Takei H; Liu YL; Silverman JE; Lipscomb JT; Ruiz B
Acta Cytol; 2006; 50(1):48-54. PubMed ID: 16514840
[TBL] [Abstract][Full Text] [Related]
23. In Papanicolaou smears, benign appearing endometrial cells bear no significance in predicting uterine endometrial adenocarcinomas.
Moatamed NA; Le LT; Levin MR; Govind R; Apple SK
Diagn Cytopathol; 2013 Apr; 41(4):335-41. PubMed ID: 22102567
[TBL] [Abstract][Full Text] [Related]
24. The significance of benign endometrial cells in cervicovaginal smears.
Fadare O; Ghofrani M; Chacho MS; Parkash V
Adv Anat Pathol; 2005 Sep; 12(5):274-87. PubMed ID: 16210924
[TBL] [Abstract][Full Text] [Related]
25. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU
Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
[TBL] [Abstract][Full Text] [Related]
26. Investigations for postmenopausal uterine bleeding: special considerations for endometrial volume.
Cho HJ; Lee ES; Lee JY; Hong SN; Ji YI; Kim HY; Kim A
Arch Iran Med; 2013 Nov; 16(11):665-70. PubMed ID: 24206410
[TBL] [Abstract][Full Text] [Related]
27. [The significance of endometrial cells in the cervical smear].
Doornewaard H; Sie-Go DM; Woudt JM; Kooijman CD
Ned Tijdschr Geneeskd; 1993 Apr; 137(17):868-72. PubMed ID: 8487901
[TBL] [Abstract][Full Text] [Related]
28. Significance of benign endometrial cells in papanicolaou tests from women aged >or=40 years.
Thrall MJ; Kjeldahl KS; Savik K; Gulbahce HE; Pambuccian SE
Cancer; 2005 Aug; 105(4):207-16. PubMed ID: 15900572
[TBL] [Abstract][Full Text] [Related]
29. Age cut-off for reporting endometrial cells on a Papanicolaou test: 50 years may be more appropriate than 45 years.
Weiss VL; Cate F; Bloom L; Fadare O; Coogan AC; Desouki MM
Cytopathology; 2016 Aug; 27(4):242-8. PubMed ID: 26689647
[TBL] [Abstract][Full Text] [Related]
30. Incidence and clinical significance of morphologically benign-appearing endometrial cells in patients age 40 years or older: the impact of the 2001 Bethesda System.
Bean SM; Connolly K; Roberson J; Eltoum I; Chhieng DC
Cancer; 2006 Feb; 108(1):39-44. PubMed ID: 16329117
[TBL] [Abstract][Full Text] [Related]
31. [The value of transvaginal ultrasonography in the follow-up of postmenopausal women's endometrium].
Tica VI; Beghim M; Cristurean V; Zaher M; Beghim E; Bafani S; Tica I
Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):889-93. PubMed ID: 17438895
[TBL] [Abstract][Full Text] [Related]
32. The validity of Pap smear parameters as predictors of endometrial pathology in menopausal women.
Zucker PK; Kasdon EJ; Feldstein ML
Cancer; 1985 Nov; 56(9):2256-63. PubMed ID: 4052970
[TBL] [Abstract][Full Text] [Related]
33. Significance of histiocytes in cervical smears from peri/postmenopausal women.
Tambouret R; Bell DA; Centeno BA
Diagn Cytopathol; 2001 Apr; 24(4):271-5. PubMed ID: 11285625
[TBL] [Abstract][Full Text] [Related]
34. Age cutoff for reporting of benign-appearing endometrial cells in Papanicolaou specimens; should it be raised? A 10-year retrospective study from a large county hospital.
Hinson S; Molberg K; Mir M; Flores M; Zheng W; Lucas E
J Am Soc Cytopathol; 2019; 8(2):78-83. PubMed ID: 31287423
[TBL] [Abstract][Full Text] [Related]
35. The value of outpatient hysteroscopy in diagnosing endometrial pathology in postmenopausal women with and without hormone replacement therapy.
Elliott J; Connor ME; Lashen H
Acta Obstet Gynecol Scand; 2003 Dec; 82(12):1112-9. PubMed ID: 14616256
[TBL] [Abstract][Full Text] [Related]
36. Endometrial cells in pap smears of postmenopausal women: cytohistologic correlation.
Cai N; Spitzer M; Wasserman PG
J Low Genit Tract Dis; 2003 Oct; 7(4):250-3. PubMed ID: 17051079
[TBL] [Abstract][Full Text] [Related]
37. How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding.
Smith-Bindman R; Weiss E; Feldstein V
Ultrasound Obstet Gynecol; 2004 Oct; 24(5):558-65. PubMed ID: 15386607
[TBL] [Abstract][Full Text] [Related]
38. Normal endometrial cells in Papanicolaou smears: prevalence in women with and without endometrial disease.
Gomez-Fernandez CR; Ganjei-Azar P; Behshid K; Averette HE; Nadji M
Obstet Gynecol; 2000 Dec; 96(6):874-8. PubMed ID: 11084170
[TBL] [Abstract][Full Text] [Related]
39. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
[TBL] [Abstract][Full Text] [Related]
40. Rebleeding and endometrial growth in women with postmenopausal bleeding and endometrial thickness < 5 mm managed by dilatation and curettage or ultrasound follow-up: a randomized controlled study.
Epstein E; Valentin L
Ultrasound Obstet Gynecol; 2001 Nov; 18(5):499-504. PubMed ID: 11844172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
